Skip to content

Frontlight ResearchEarly access

Trial site

Erasmus Medical Center

Rotterdam, 3015, NetherlandsNot linked to an institution yet

57running trials
23closed trials

The trials here

What the 81 trials at this site are about, from their registry records.

Conditions: Glioblastoma7 trials
Coronary artery disease6 trials
Ovarian cancer5 trials
Gastric and oesophageal cancer4 trials
Head and neck cancer4 trials
Heart failure4 trials
Ventricular tachycardia4 trials
Aortic stenosis3 trials
Atrial fibrillation3 trials
Colorectal cancer3 trials
Atopic dermatitis (eczema)2 trials
Barrett's oesophagus2 trials
and 34 more
Phase: Phase 311 trials
Phase 26 trials
Phase 1/24 trials
Phase 44 trials
Phase 12 trials
Status: Recruiting26 trials
Completed20 trials
Active, not recruiting17 trials
Not yet recruiting12 trials
Enrolling by invitation2 trials
Terminated2 trials
Suspended1 trial
Withdrawn1 trial
Lead sponsor: Erasmus Medical Center19 trials
Jasper Gerritsen3 trials
Leiden University Medical Center3 trials
Radboud University Medical Center3 trials
University Medical Center Groningen3 trials
and 42 more

Running trials

Recruiting
Thermotherapy for Head and Neck Cancer Patients
NCT07690618· Phase 1· Erasmus Medical Center· Source
Contact: Michiel Kroesen, MD, Dr.
Recruiting
Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy
NCT07435987· Erasmus Medical Center· Source
Contact: H. Westerveld, MD, PhD
Recruiting
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
NCT07324031· AtaCor Medical, Inc.· Source
Contact: Sing Yap, MD
Not yet recruiting
Sweet & Sour: Dietary Acid Load in Type 2 Diabetes and Kidney Disease Across Sex and Ethnic Groups
NCT07587918· Erasmus Medical Center· Source
Contact: Ilias Attaye, Dr.
Recruiting
Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial
NCT05752149· Phase 2· Erasmus Medical Center· Source
Contact: Stijn Keereweer, MD, PhD
Recruiting
Hypothermic Machine Perfusion With Omnisol of Deceased Donor Kidneys Prior to Transplantation
NCT07792317· Vivalyx GmbH· Source
Contact: Robert Minnee, MD PhD
Recruiting
Respiratory Muscles in End-stage Lung Disease: Pathophysiological Processes & Clinical Consequences
NCT06935825· University Medical Center Groningen· Source
Contact: Merel Hellemons, MD PhD
Recruiting
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
NCT07021495· Leiden University Medical Center· Source
Contact: Martijn van Doorn, MD, PhD
Recruiting
Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
NCT06571149· Phase 4· Insel Gruppe AG, University Hospital Bern· Source
Not yet recruiting
Unraveling the Blood Microbiome in Postoperative Recurrence of Crohn's Disease
NCT06770140· Erasmus Medical Center· Source
Contact: Merel Verweij, MD
Recruiting
FCV vs VCV in Obstructive and Asthmatic Patients
NCT06563544· Erasmus Medical Center· Source
Contact: Gommers, Professor
Not yet recruiting
Part of the Modern Art Study
NCT06768242· Erasmus Medical Center· Source
Contact: Alejandra Méndez Romero, MD, PhD
Not yet recruiting
Growing up With the Young Endocrine Support System (YESS!)
NCT04252001· dr. Laura C. G. de Graaff-Herder· Source
Contact: Laura CG de Graaff, MD, PhD
Recruiting
Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas
NCT05851534· Maastricht University Medical Center· Source
Contact: Bas Groot Koerkamp, MD PhD
Active, not recruiting
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)
NCT06625398· Phase 3· Viridian Therapeutics, Inc.· Source
Active, not recruiting
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)
NCT06625411· Phase 3· Viridian Therapeutics, Inc.· Source
Recruiting
Patient-led Follow-up from Home After Surgery for Colorectal Carcinoma
NCT06613581· Erasmus Medical Center· Source
Contact: Dirk J. Grunhagen, MD, PhD
Active, not recruiting
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion
NCT06029660· Shape Memory Medical, Inc.· Source
Active, not recruiting
Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE)
NCT06181240· Bolt Medical· Source
Recruiting
Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
NCT06183983· Erasmus Medical Center· Source
Contact: Patrick Tang, MSc
Recruiting
The MAGiC™ Cardiac Ablation European Study
NCT06019845· Stereotaxis· Source
Contact: Elco van der Heide
Recruiting
The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)
NCT06138223· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Source
Contact: Bianca Mostert, MD
Recruiting
Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.
NCT05333523· Phase 3· Radboud University Medical Center· Source
Contact: Dr. J.B.W. Elbers, MD, PhD
Recruiting
Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm
NCT05779631· Radboud University Medical Center· Source
Contact: A. G. van der Heijden, Dr.
Enrolling by invitation
Cryoablation of Brain Neoplasm
NCT06753617· Erasmus Medical Center· Source
Active, not recruiting
DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema
NCT06004986· Phase 4· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Source
Recruiting
A Study on the Effects of Left Ventricular Unloading in the Setting of VA ECMO Support
NCT05913622· Erasmus Medical Center· Source
Contact: Myrthe V Steenwijk
Recruiting
Effects Branch PA Stenting d-TGA, ToF and TA
NCT05809310· UMC Utrecht· Source
Contact: Thomas B Krasemann, MD, PhD
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120· Weill Medical College of Cornell University· Source
Contact: Sabrine Siregar, MD
Recruiting
EMR Versus ESD for Barrett's Neoplasia
NCT05276791· St. Antonius Hospital· Source
Contact: dr. A. Koch
Active, not recruiting
C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study.
NCT03311451· Merit Medical Systems, Inc.· Source
Recruiting
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
NCT06273176· Erasmus Medical Center· Source
Contact: Jasper Gerritsen, MD PhD
Recruiting
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
NCT06146725· Jasper Gerritsen· Source
Contact: Jasper Gerritsen, MD PhD
Recruiting
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
NCT06146738· Jasper Gerritsen· Source
Contact: Jasper Gerritsen, MD PhD
Recruiting
LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.
NCT05682482· Phase 3· M. Medici· Source
Contact: Marco Medici, MD PhD
Recruiting
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
NCT05491200· Phase 4· Research Maatschap Cardiologen Rotterdam Zuid· Source
Contact: Nicolas van Mieghem, PHD
Active, not recruiting
Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
NCT05970757· Erasmus Medical Center· Source
Active, not recruiting
Study of INCB123667 in Subjects With Advanced Solid Tumors
NCT05238922· Phase 1· Incyte Corporation· Source
Active, not recruiting
DAPAgliflozin for Renal Protection in Heart Transplant Recipients
NCT05321706· Phase 3· Oslo University Hospital· Source
Recruiting
PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer
NCT05406856· Leiden University Medical Center· Source
Contact: Remi A. Nout, professor
Active, not recruiting
Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)
NCT05318612· Phase 3· Radboud University Medical Center· Source
Recruiting
The DRAGON 2 Trial
NCT05428735· Maastricht University· Source
Contact: Dirk J. Grünhagen, MD PhD
Recruiting
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
NCT06118723· Jasper Gerritsen· Source
Contact: Jasper Gerritsen, MD PhD
Recruiting
PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions
NCT05230446· Erasmus Medical Center· Source
Contact: Roberto Diletti, MD, PhD
Active, not recruiting
ACURATE neo2™ Post Market Clinical Follow up Study
NCT04655248· Boston Scientific Corporation· Source
Recruiting
Prospective Bladder Cancer Infrastructure (ProBCI)
NCT04503577· Prospective Bladder Cancer Infrastructure Foundation· Source
Contact: A. Richters, PhD
Active, not recruiting
A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
NCT04093349· Phase 1/2· Spark Therapeutics, Inc.· Source
Recruiting
PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy
NCT04642027· Phase 3· University Medical Center Groningen· Source
Contact: L. Incocci, Professor
Recruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT04294927· University Medical Center Nijmegen· Source
Contact: Eva Roes, MD, PhD
Recruiting
FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test
NCT06193525· Phase 2· Erasmus Medical Center· Source
Contact: Clinical Trial Center

Showing 50 of 57.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Glioblastoma5 recruiting
Coronary artery disease3 recruiting
Head and neck cancer3 recruiting
Ventricular tachycardia3 recruiting
Bladder cancer2 recruiting
Cervical cancer2 recruiting
Chronic kidney disease2 recruiting
Colorectal cancer2 recruiting
Gastric and oesophageal cancer2 recruiting
Liver and biliary tract cancer2 recruiting
Turner syndrome2 recruiting
Asthma1 recruiting
Atopic dermatitis (eczema)1 recruiting
Atrial fibrillation1 recruiting
Barrett's oesophagus1 recruiting
Childhood cancers1 recruiting
Congenital heart disease1 recruiting
COPD1 recruiting
Crohn's disease1 recruiting
Hidradenitis suppurativa1 recruiting
Hypothyroidism1 recruiting
Meningioma1 recruiting
Metastatic breast cancer1 recruiting
Ovarian cancer1 recruiting
Pancreatic cancer1 recruiting
Prostate cancer1 recruiting
Psoriasis1 recruiting
Stroke1 recruiting
Type 2 diabetes1 recruiting

Closed trials

Withdrawn
PREcision meDICine in Treatment in CardioVascular Disease
NCT07369141· Maastricht University Medical Center· Source
Completed
The Added Value of Three-dimensional Electroanatomic Mapping For Accurate Delivery Of Pulsed Field Ablation In The Pulmonary Veins Compared To Pulsed Field Ablation With Fluoroscopy And/Or Intracardiac Echocardiography Alone In The Treatment Of Atrial Fibrillation: MAP-PFA Study
NCT07014423· University Medical Center Groningen· Source
Not yet recruiting
Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG
NCT07118449· Phase 2· XyloCor Therapeutics, Inc.· Source
Completed
Effect of a Bigger Cryoballoon on the Total Antral Lesion Size: Evaluation of POLARx FIT
NCT05881733· Erasmus Medical Center· Source
Completed
The Pharmacological Effects of Using Cabozantinib With a Light Breakfast
NCT05263245· Phase 2· dr. Tom van der Hulle· Source
Completed
Investigation of the ALLEGRA THV System With a New Delivery System in Patients With Aortic Stenosis or Failed Surgical Bioprosthesis
NCT05478161· NVT GmbH· Source
Completed
International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project
NCT05387811· Azienda Ospedaliera di Padova· Source
Completed
Cortical Excitability and Treatment Response in People with Epilepsy
NCT05551403· Stichting Epilepsie Instellingen Nederland· Source
Completed
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM
NCT05186818· Phase 3· Cytokinetics· Source
Completed
A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation
NCT05076149· Phase 3· Vertex Pharmaceuticals Incorporated· Source
Completed
VIVO European Observational Registry
NCT04990089· Catheter Precision. Inc.· Source
Completed
TEIPP Immunotherapy in Patients With NSCLC
NCT05898763· Phase 1/2· Erasmus Medical Center· Source
Completed
Adherence to Lifestyle Changes for Age-related Macular Degeneration
NCT05667441· Erasmus Medical Center· Source
Terminated
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
NCT04868877· Phase 1/2· Merus B.V.· Source
Completed
US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia
NCT04103879· Phase 2· ExCellThera inc.· Source
Completed
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression
NCT04209855· Phase 3· AbbVie· Source
Terminated
Functional Analysis of BRCAness
NCT04780945· Phase 2· Leiden University Medical Center· Source
Completed
Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma
NCT03391466· Phase 3· Kite, A Gilead Company· Source
Completed
First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221
NCT02675465· Phase 1/2· Amicus Therapeutics· Source
Recruiting
@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms
NCT05526352· University Hospital, Geneva· Source
Contact: Sven Hirsch, Dr
Completed
Top-down Infliximab Study in Kids With Crohn's Disease
NCT02517684· Phase 4· Erasmus Medical Center· Source
Completed
Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold
NCT02539966· REVA Medical, Inc.· Source
Completed
Laparoscopic Versus Open Gastrectomy for Gastric Cancer
NCT02248519· UMC Utrecht· Source

Site data: ClinicalTrials.govUpdated 14 Nov 2026

Report an error